1. Home
  2. ERO vs ALVO Comparison

ERO vs ALVO Comparison

Compare ERO & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ero Copper Corp.

ERO

Ero Copper Corp.

HOLD

Current Price

$25.31

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$5.54

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERO
ALVO
Founded
2016
2013
Country
Canada
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ERO
ALVO
Price
$25.31
$5.54
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$25.00
$9.25
AVG Volume (30 Days)
1.0M
544.6K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
696.31
N/A
EPS
1.33
0.24
Revenue
$588,229,000.00
$573,350,000.00
Revenue This Year
$68.14
$20.97
Revenue Next Year
$46.45
$43.04
P/E Ratio
$18.98
$23.19
Revenue Growth
26.74
45.55
52 Week Low
$9.30
$4.32
52 Week High
$26.77
$13.70

Technical Indicators

Market Signals
Indicator
ERO
ALVO
Relative Strength Index (RSI) 62.16 48.24
Support Level $23.60 $5.23
Resistance Level $25.93 $5.85
Average True Range (ATR) 1.14 0.32
MACD 0.06 0.17
Stochastic Oscillator 72.48 80.07

Price Performance

Historical Comparison
ERO
ALVO

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Share on Social Networks: